Beyond Meds highlights a reappraisal of Andrew Solomon, whose book “The Noonday Demon: An Atlas of Depression” is often pointed to as testimony for the effectiveness of psychiatric treatment. Solomon’s trajectory, the article claims, could be understood to be a tragedy of iatrogenic problems and withdrawal, culminating in Solomon’s father – a pharma executive who tauted psychopharmaceuticals in part as a result of his belief that his son had benefitted from them – being targeted by the U.S. Office of the Inspector General for overly aggressive marketing of antidepressants.
Thanks for pointing out this fascinating article. I didn’t know this about Andrew Solomon. I heard a radio broadcast of his “Identity/Far from the tree” TED talk recently and was very impressed and touched. I never heard about his book “Noonday demon,” or the pharmaceutical scandal surrounding his CEO father. Very interesting.